Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Free Radical Biology & Medicine
|
February 6, 2013
Parkinson disease: from pathology to molecular disease mechanisms
David T Dexter, Peter Jenner
Journal of Neurochemistry
|
November 15, 2013
Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease
Claire J Williams, David T Dexter
Pharmacology & Therapeutics
|
December 3, 2011
Voltage-gated calcium channels and Parkinson's disease
Michael J Hurley, David T Dexter
Pharmacology & Therapeutics
|
May 29, 2013
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Ian F Harrison, David T Dexter
International Journal of Molecular Sciences
|
July 9, 2022
Iron, Neuroinflammation and Neurodegeneration
Roberta J Ward, David T Dexter, Robert R Crichton
Neuroscience Letters
|
January 9, 2016
Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
Ian F Harrison, Hiba K Anis, David T Dexter
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
February 27, 2015
Neurodegenerative diseases and therapeutic strategies using iron chelators
Roberta J Ward, David T Dexter, Robert R Crichton
Journal of Neurochemistry
|
October 1, 2018
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
Ian F Harrison, Nicholas M Powell, David T Dexter
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 3, 2010
Brain iron metabolism and its perturbation in neurological diseases
Robert R Crichton, David T Dexter, Roberta J Ward
Journal of Molecular Neuroscience : MN
|
September 1, 2014
Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization
Michael J Hurley, Steve M Gentleman, David T Dexter
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Free Radical Biology & Medicine
|
February 6, 2013
Parkinson disease: from pathology to molecular disease mechanisms
David T Dexter, Peter Jenner
Journal of Neurochemistry
|
November 15, 2013
Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease
Claire J Williams, David T Dexter
Pharmacology & Therapeutics
|
December 3, 2011
Voltage-gated calcium channels and Parkinson's disease
Michael J Hurley, David T Dexter
Pharmacology & Therapeutics
|
May 29, 2013
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Ian F Harrison, David T Dexter
International Journal of Molecular Sciences
|
July 9, 2022
Iron, Neuroinflammation and Neurodegeneration
Roberta J Ward, David T Dexter, Robert R Crichton
Neuroscience Letters
|
January 9, 2016
Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
Ian F Harrison, Hiba K Anis, David T Dexter
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)
|
February 27, 2015
Neurodegenerative diseases and therapeutic strategies using iron chelators
Roberta J Ward, David T Dexter, Robert R Crichton
Journal of Neurochemistry
|
October 1, 2018
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
Ian F Harrison, Nicholas M Powell, David T Dexter
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 3, 2010
Brain iron metabolism and its perturbation in neurological diseases
Robert R Crichton, David T Dexter, Roberta J Ward
Journal of Molecular Neuroscience : MN
|
September 1, 2014
Calcium CaV1 channel subtype mRNA expression in Parkinson's disease examined by in situ hybridization
Michael J Hurley, Steve M Gentleman, David T Dexter
Page
of 7